inno-train

What inno-train does

inno-train Diagnostik GmbH is a privately held German in-vitro diagnostics (IVD) manufacturer founded in 1998 and headquartered in Kronberg im Taunus, with a North American division in Clinton, New York, established in 2018. The company develops and produces molecular diagnostic kits, automation instruments, and analysis software for transfusion and transplantation medicine, specifically HLA, HPA, RBC (blood group), and KIR typing used by clinical laboratories, transplant centers, blood banks, and immunohematology reference labs.

Its core technology stack spans four diagnostic modalities: serology (HLA-Ready Plate and RBC Serology), SSP-PCR (Ready Gene product lines for HLA, HPA, RBC, and KIR), TaqMan-based real-time PCR (FluoGene systems for HLA, HPA, and RBC including the RBC-FluoGene Q liquid mix line), and Illumina-based next-generation sequencing (HLA-SuBiTo NGStype and RBC-NGStype). These are supported by proprietary automated instruments (BEXS 12 for DNA/RNA extraction, FluoQube and FluoQube384 real-time cyclers) and dedicated software (FluoGene Software, NGStype Software, Ready Gene Online) with LIMS export. The company also distributes DaraEx (anti-CD38 neutralizing agent) and recombinant blood group antigens under a worldwide agreement with imusyn.

Revenue is generated through one-time sales of IVD kits (HLA, HPA, RBC, KIR consumables across SSP-PCR, real-time PCR, and NGS), instrument sales (FluoQube line, BEXS 12), software licensing, and paid training/support services. Distribution combines a direct sales force in Germany and North America with a distributor network spanning 50+ countries, supported by active participation in EFI, ISBT, ASHI, and AABB conferences and the company's own annual Molecular Blood Group Forum in Frankfurt. The company has been ISO 13485-certified since 2003 (audited annually by TÜV SÜD) and, in February 2026, achieved IVDR 2017/746 certification for its HLA-Ready Gene and HLA-FluoGene product lines plus the HLA part of FluoGene Software. It receives non-dilutive EU ERDF co-funding for the ongoing RBC-NGStype BloodSeq NGS kit development project.

Name

inno-train

Legal name

inno-train Diagnostik GmbH

Website

https://inno-train.de

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

inno-train Diagnostik GmbH is a German in-vitro diagnostics manufacturer founded in 1998, supplying molecular diagnostic kits, instruments, and software for HLA, HPA, RBC, and KIR typing to clinical laboratories, transplant centers, and blood banks in over 50 countries.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics for Transfusion Medicine

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• Molecular diagnostics kits
• HLA typing
• Blood group genotyping
• Transfusion medicine diagnostics
• Immunohematology reagents

Headquarters

HQ city

Kronberg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. IVD Diagnostic Kits: Sale of molecular diagnostic kits for HLA typing, blood group typing (RBC), and human platelet antigens (HPA) including SSP-PCR, Real-Time PCR, and NGS-based products. Products sold as ready-to-use kits with proprietary primer/probe mixes.
2. Laboratory Instruments: Sale of real-time PCR instruments (FluoQube, FluoQube384), DNA extraction systems (BEXS 12), and automation equipment.
3. Software Licenses: Licensing of FluoGene Software, NGStype Software, and Ready Gene Online for data analysis and result interpretation.
4. Training and Support Services: In-person and online training workshops, webinars, and technical support services for customers and distributors.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

inno-train Diagnostik GmbH manufactures and supplies in-vitro diagnostic kits, automation instruments, and analysis software for transfusion and transplantation medicine. Its product portfolio covers HLA, HPA, RBC, and KIR typing across four methodologies—serology, SSP-PCR, Real-Time PCR (TaqMan-based SSP), and Next Generation Sequencing—supported by proprietary instruments (FluoQube, FluoQube384, BEXS 12), dedicated software (FluoGene, NGStype, Ready Gene Online), and distributed products (DaraEx, recombinant blood group antigens). The complete integrated workflow runs from automated DNA extraction through PCR amplification to software-based result interpretation.

Product overview

inno-train Diagnostik GmbH is a German in-vitro diagnostics company founded in 1998, offering a comprehensive portfolio for transfusion medicine and immunohematology. The product ecosystem consists of four core testing methodologies: Serology (HLA-Ready Plate, RBC Serology), SSP-PCR (HLA-Ready Gene, HPA-Ready Gene, RBC-Ready Gene, KIR Ready Gene), Real-Time PCR (HLA-FluoGene, HPA-FluoGeneNX, RBC-FluoGene, RBC-FluoGene Q), and Next Generation Sequencing (HLA-SuBiTo NGStype, RBC-NGStype). The complete workflow is supported by automation instruments (BEXS 12 for DNA extraction, FluoQube/FluoQube384 for real-time PCR, FluoVista for endpoint fluorescence reading), analysis software (FluoGene Software, NGStype Software, Ready Gene Online), and distributed products (DaraEx, Recombinant Blood Group Antigens from imusyn). The company holds ISO 13485:2016 certification, IVDR 2017/746 certification for HLA products, and serves customers in over 50 countries with headquarters in Kronberg, Germany and a North American division in Clinton, New York.

Differentiator

Problem solved

Functional benefit

Brands

• FluoGene: Automation system for molecular diagnostics combining DNA extraction, automated testing, real-time instruments, and software for result analysis
• Ready Gene
• FluoQube
• FluoQube384
• BEXS 12
• NGStype
• DaraEx
• Recombinant Blood Group Antigens (rBGA)
• RBC-FluoGene Q
• RBC-NGStype

Products and services

• HLA-Ready Gene
• HLA-SuBiTo NGStype
• HLA-Ready Plate
• HLA-FluoGene
• HPA-Ready Gene
• HPA-FluoGeneNX
• RBC-Ready Gene
• RBC-NGStype
• RBC-FluoGene
• RBC-FluoGene Q
• KIR Ready Gene
• FluoQube
• FluoQube384
• BEXS 12
• FluoGene Software
• NGStype Software
• Ready Gene Online
• DaraEx
• Recombinant Blood Group Antigens (rBGA)

Quantifiable outcome

• DNA extraction purity A260/A280 ~ 1.8 with 5-10 μg yield from 250 μL blood
• +4 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration6 records

Feature9 records

Partnerships

Four partnerships are on record, tiered core.

• imusyncoreTechnology or Integrationimusyn is a German biotechnology company whose serological products (DaraEx and recombinant blood group antigens) inno-train distributes worldwide. DaraEx neutralizes therapeutic anti-CD38 antibodies interfering with pretransfusion testing. inno-train acquired sales rights for these products and distributes them globally since March 1st.
• IlluminacoreTechnology or Integrationinno-train's NGS products (HLA-NGStype, RBC-NGStype) are designed for Illumina sequencing platforms. The RBC-NGStype CORE kit runs on Illumina MiSeq Nano (0.3 Gb) Flow Cell and works with all Illumina platforms.
• Immunohematology Reference Laboratories and Opinion LeaderscoreStrategic or Co-development Partnerinno-train collaborates with immunohematology reference laboratories and opinion leaders for product development. Products developed in close collaboration with experts including Prof. Dr. Christoph Gassner.
• Prof. Dr. Christoph GassnercoreStrategic or Co-development PartnerProduct developed in collaboration with Prof. Dr. Christoph Gassner (Private University in the Principality of Liechtenstein). Expert contributor to Molecular Blood Group Forum and product validation.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Immucor: Immucor is a direct competitor in transfusion and transplant diagnostics, manufacturing serology, SSP-PCR, and molecular blood bank reagents — the same workflow categories in which inno-train competes for hospital blood bank and immunohematology lab accounts.
• Bio-Rad Laboratories: Bio-Rad's ID-Card LISS/Coombs gel cards are explicitly listed as compatible with inno-train's recombinant blood group antigens, and Bio-Rad is a major vendor of HLA and blood bank reagents; it is a direct competitor for serology and ancillary transfusion medicine consumables worldwide.
• Grifols: Grifols' DG Gel Coombs gel cards are listed as compatible with inno-train's recombinant blood group antigens; Grifols is one of the largest global suppliers of blood bank serology and immunohematology products, directly overlapping with inno-train's transfusion diagnostics portfolio.
• Thermo Fisher Scientific (One Lambda): One Lambda, part of Thermo Fisher, is a global leader in HLA typing kits and software for transplantation diagnostics, competing head-to-head with inno-train's HLA-Ready Gene, HLA-FluoGene, and HLA-SuBiTo NGStype product lines for transplant center business.
• GenDx: GenDx (now under Eurobio Scientific) is a specialist in NGS and Sanger-based HLA and KIR typing reagents and software, directly competing with inno-train's NGStype and HLA-SSP product lines for transplant immunogenetics laboratories.
• CareDx: CareDx focuses on transplant surveillance and HLA-based diagnostics for solid organ and stem cell transplant centers, overlapping with inno-train's transplantation diagnostics customer base and HLA typing offering.

Broad incumbents

• QIAGEN: QIAGEN is a broad molecular diagnostics and sample-preparation incumbent whose QIAcube and PCR reagents partially overlap with inno-train's BEXS 12 extraction system and SSP/qPCR kit offerings, although it is not focused exclusively on transfusion medicine.
• Hologic: Hologic is a diversified diagnostics incumbent whose Panther and molecular IVD platforms serve reference labs that also purchase HLA, RBC, and HPA reagents, making it a broad-incumbent alternative for some of inno-train's clinical lab customers.
• Becton, Dickinson and Company (BD): BD's Life Sciences and Diagnostic Systems segments include blood collection, molecular reagents, and flow cytometry used by blood banks and immunogenetics labs; BD Life Sciences competes broadly for the same lab budgets as inno-train, though it does not specialize in transfusion IVD kits.

Emerging players

• Cepheid (Danaher): Cepheid's GeneXpert molecular systems are deployed in hospital and reference labs that also buy immunohematology reagents; while not focused on blood group typing, the platform-level overlap in molecular IVD lab workflows makes Cepheid an adjacent competitive reference for inno-train's molecular IVD customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/inno-train-diagnostik-gmbh

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about inno-train